ZEAL - SAVE THE DATE: Zealand Pharma to host Obesity R&D Event in London on December 5 2023 | Benzinga
Press release – No. 11 / 2023
SAVE THE DATE: Zealand Pharma to host Obesity R&D Event in London on December 5, 2023
Copenhagen, Denmark, September 8, 2023 – Zealand Pharma A/S (NASDAQ:ZEAL) (CVR-no. 20045078), a biotechnology company focused on the discovery and development of innovative peptide-based medicines, today announced that it will host an Obesity R&D Event in London on December 5, 2023 with management and external scientific experts in obesity.
"The growing prevalence of people living with obesity and associated comorbidities represents one of the biggest challenges for healthcare systems globally. At Zealand, our robust and differentiated pipeline of drug candidates may help shape the future management of obesity", said Adam Steensberg, President and Chief Executive Officer at Zealand Pharma.
"At our December 5th Obesity R&D day we look very much forward to ...